Charlotteans 4 Cancer Cure

CHOOSING HOPE FOR CHARLOTTEANS FIGHTING CANCER

 

 

 

 

About Charlotteans 4 Cancer Cure:

Charlotteans 4 Cancer Cure (C4CC) was established in 2012 by a group of women in the 18-Hole Ladies Golf Association at Carmel Country Club. It is a philanthropic group raising funds to help bring cutting-edge cancer treatment to Charlotte and the Carolinas. Many of these women and their families have been touched by cancer and their combined efforts have now raised over $140,000. The Phase 1 Clinical Trials Family Waiting Room received a recognition plaque naming Charlotteans 4 Cancer Cure in August 2014. In addition, another C4CC plaque was dedicated and placed  at the Levine Cancer Institute Pharmacy in 2016.

 

 

 

Pictured: Members of the C4CC present a check at Levine Cancer Institute.

Pictured above: The 2016 Charlotteans 4 Cancer Cure Tribute Wall.

Pictured above: The Charlotteans 4 Cancer Cure Committee before our golf tournament.

Pictured above: Pauline Jackson and Ingrid Amols at Swoozie’s fundraiser for C4CC.

 

About LCI and The Cancer Research and Innovations Fund

Levine Cancer Institute (LCI) was formed by Atrium Health as a part of an innovative vision to bring world-class cancer care directly to the Carolinas region.  Building upon Atrium Health’s extensive network of cancer centers throughout the Carolinas, LCI is comprised of community-based cancer programs that advance the highest level of cancer treatment, scientific research, education, survivorship care, and prevention programming close to where patients live.  The Institute also facilitates access to specialists, clinical trials, and important support services.

LCI has recruited oncologists from top-ranked programs across the country and has grown to include a network of more than 17 locations throughout the Carolinas, caring for approximately 15,000 new cancer cases yearly.  The headquarters facility in Charlotte includes a Phase I clinical trials unit, which supports cutting edge research including novel therapies in the earliest stages of development.  Clinical activity at this location also includes care for patients with rare and complex cancer conditions.  LCI’s ultimate goal is to reduce cancer incidence, increase survivorship rates, and improve the level of wellness among cancer patients in the Carolinas, while reducing the need for patients to travel long distances to receive comprehensive, coordinated, specialized care.

Access to early phase clinical trials allows additional options for cancer patients.  These clinical trials are only conducted at a small number of specialized centers across the country and LCI is one of these institutions. Recently, a novel treatment for a special type of lung cancer was reported in the New England Journal of Medicine (April 2015).  LCI was one of only four US institutions to be included in this report.